6 Best Peptides for Jet Lag

What to Know Before Choosing a Peptide for Jet Lag

A peptide earns a place in this guide because people use it for jet lag, or are actively discussing using it. That is the whole test. FDA-approved, telemedicine-prescribed, and research-only compounds are all eligible, and evidence strength is described honestly inside each entry rather than used as a filter at the door. A compound with only community-reported use is included here with that fact stated plainly. A compound with stronger research behind it gets that stated plainly too.

The entries are numbered, but those numbers reflect how prominently each compound appears in research and real-world use for jet lag, not a ranking of one being better than another for you. Sleep disruption, circadian drift, brain fog, travel anxiety, and immune vulnerability can all show up in the same trip, and the compound that fits depends on which of those is your primary problem, how often you travel, and what else is in your protocol.

One framing point before the entries: melatonin and the synthetic melatonin-receptor agonist tasimelteon carry the strongest human clinical trial evidence for jet lag of anything discussed on or off this list. A randomized study of 474 travelers found melatonin reduced subjective jet lag by roughly 50 percent, and that baseline matters. The peptides below are used alongside the established options, not as replacements for them.

1. DSIP: For Deep Sleep Restoration at the Destination

Delta Sleep-Inducing Peptide, almost universally called DSIP, is a nine-amino-acid neuropeptide first identified in the 1970s. It has accumulated more than 500 published papers since its discovery, which makes it one of the better-studied neuropeptides in this guide, though that phrase deserves context: no large-scale randomized controlled trial has been published specifically for jet lag, and the compound remains experimental and investigational for this use as of 2026.

What the research does show is how DSIP works at a mechanistic level. It crosses the blood-brain barrier via a saturable transport system, meaning it physically reaches the brain rather than acting only at the periphery. Once there, it does not behave like a traditional sedative. It does not force sleep the way a conventional hypnotic would. Instead, it appears to bias sleep architecture toward slow-wave, deep sleep, the stage that jet lag most aggressively strips away. The underlying pathway involves modulation of GABAergic, serotonergic, and dopaminergic signaling, a set of neurotransmitter systems that govern how the brain transitions between waking and sleep states.

The biohacking and high-performance travel community has landed on DSIP as its first-line peptide choice for jet lag, and the rationale is straightforward: the most immediate and disabling symptom of a major time-zone crossing is the inability to sleep when the destination clock says you should. User-reported experience from community protocols describes faster sleep onset, fewer nighttime awakenings, and a sense of genuine rest rather than just logged horizontal hours. One detailed protocol from a biohacking community claims compression of the adjustment window from roughly six days down to two or three days for a six-hour eastward shift, with DSIP as the core component, though that account is anecdotal rather than measured in controlled research.

DSIP is not available over the counter. In the United States it is classified as a research chemical and, where prescribed, is dispensed through licensed compounding pharmacies under physician supervision. It is also available as an intranasal spray in compounded form, which some users prefer for travel. People whose primary jet lag problem is broken sleep tend to reach for this one first.

2. Epitalon: For Circadian Clock Reset at the Source

Epitalon is a synthetic tetrapeptide derived from Epithalamin, a natural peptide the pineal gland produces. Its mechanism operates upstream from the sleep symptoms DSIP addresses. Where DSIP manages sleep architecture night to night, Epitalon's studied effects relate to pineal gland function and melatonin regulation, meaning it targets the biological source of circadian timekeeping rather than the acute symptom of disrupted sleep.

The pineal gland produces melatonin in response to darkness, and the rhythm of that production is a primary signal the body uses to know what time it is. Jet lag breaks the synchrony between that internal signal and the environmental light-dark cycle at the destination. Epitalon's proposed role is to support and normalize pineal function, helping the gland recalibrate its melatonin output to the new schedule faster than it would on its own.

No human clinical trial data has been published for Epitalon specifically in the context of jet lag as of 2026. The existing research comes primarily from Eastern European and Russian literature, where the compound has been studied in the context of aging, longevity, and hormonal regulation, including effects on pineal function over time. The jet lag application is a mechanistic extrapolation from that body of work, and community use for this purpose is well-established among frequent travelers and shift workers, though the evidence for this specific application is experiential rather than clinical.

Practitioners and community protocols consistently recommend starting Epitalon two to three days before departure, using it to prime pineal function before the disruption occurs rather than trying to recover afterward. It continues through the adjustment period at the destination. Epitalon is commonly paired with DSIP in layered protocols, with the reasoning being complementary: Epitalon addresses the upstream clock, DSIP manages sleep quality in the short term. Older adults and frequent long-haul travelers favor it particularly, because natural pineal function declines with age, making the circadian drift of jet lag compound on an already reduced baseline. In the United States, it is available through research channels and licensed compounding pharmacies and requires physician oversight.

3. Semax: For Brain Fog and Cognitive Recovery

Semax is a synthetic heptapeptide analog of a fragment of adrenocorticotropic hormone, developed originally in Russia. Its primary studied effects are neuroprotective and cognitive, making it relevant to jet lag not for sleep itself but for the brain fog, reduced executive function, and mental slowness that accompany circadian disruption and that can persist for days even after sleep begins to normalize.

The mechanism involves upregulation of brain-derived neurotrophic factor, commonly abbreviated as BDNF, a protein that supports the survival and function of neurons and plays a role in cognitive sharpness and neurological resilience. Semax also shows anti-inflammatory effects in neural tissue and appears to reduce oxidative stress in the brain. Long-haul flights are hard on the brain for reasons beyond circadian disruption alone: low cabin humidity, reduced oxygen partial pressure at altitude, disrupted circulation from prolonged sitting, and the metabolic load of crossing multiple time zones all add up. User-reported experience from biohacking and high-performance communities, including pilots and frequent business travelers, describes intranasal Semax in the morning at the destination as clearing the cognitive fog from the flight and supporting focus during work hours in the new time zone.

No human clinical trial data has been published for Semax specifically in jet lag as of 2026. The evidence here is drawn from community use rather than controlled research. Semax has a stimulatory quality, which is why community protocols place it in the morning and avoid evening use, where it could interfere with the sleep that DSIP and Epitalon are supporting at night. In the United States, Semax is available via telemedicine platforms through licensed providers and compounded pharmacies. It is not approved for aviation flight duty under FAA guidelines, a relevant consideration for pilots.

4. Selank: For Travel Anxiety and Cortisol Management

Selank is a synthetic analog of tuftsin, an endogenous immunopeptide, developed in Russia alongside Semax. Its primary studied effect is anxiolytic, meaning it reduces anxiety, and it does so through mechanisms that differ from conventional anxiolytics. Where drugs like benzodiazepines suppress the central nervous system broadly, Selank appears to modulate GABAergic and serotonergic activity in a more targeted way, with a calmer effect profile and no reported dependence or significant sedation.

Its relevance to jet lag runs through cortisol. Long-haul travel is a physiological stress event: disrupted sleep, environmental stressors in transit, the cognitive load of navigating connections, and performance pressure all drive cortisol elevation. High cortisol at the wrong point in the circadian cycle is one of the mechanisms that makes jet lag stick, because cortisol is itself a time-cue signal, and elevated cortisol at night actively opposes the melatonin rise that sleep requires. By blunting the stress response during and after travel, Selank may help keep the hormonal environment more favorable for the circadian reset the other compounds are trying to support.

The evidence for Selank in jet lag is community-reported and anecdotal. It appears regularly in practitioner protocols for pilots and flight crew, often combined with Pinealon as a circadian-plus-anxiety blend for the high-demand days after rotation. Travelers who find that anxiety or anticipatory stress about performance at the destination is a significant part of their jet lag experience tend to find a place for Selank in their approach. Like Semax, it is available intranasally in compounded form and requires physician oversight in the United States, and like Semax it falls outside FAA approval for use during flight duty.

5. Thymosin Alpha-1: For the Post-Travel Immune Window

Thymosin Alpha-1 is a thymic peptide with a well-developed body of research in immunology, studied in the context of viral infections, immune deficiency, and adjunctive oncology support. Its relevance to jet lag is specific: long-haul travel produces a documented, temporary suppression of immune function that makes frequent flyers meaningfully more vulnerable to respiratory infections in the days following a major crossing. The combination of circadian disruption, sleep loss, cabin air recirculation, and physiological stress creates a predictable immune-vulnerability window that regular travelers recognize.

Thymosin Alpha-1 supports immune function by activating T-cell maturation, a process in which immature immune cells develop into the specialized defenders the body deploys against infection, and by modulating the balance between pro- and anti-inflammatory signaling. Its human evidence base is the strongest of any compound on this list for its primary studied indications, though those indications are viral hepatitis, HIV, and oncology, not jet lag. For the travel immunity application, the evidence is practitioner-recommended and community-reported rather than derived from jet lag-specific trials, and that distinction is worth holding clearly.

What practitioners report is that frequent travelers who begin Thymosin Alpha-1 before departure and continue for roughly two weeks after travel notice fewer post-trip illnesses. That pattern is consistent enough across community protocols to earn this compound a regular slot in pre-travel stacks. It is available through licensed compounding pharmacies under physician supervision and is used specifically for the immune dimension of jet lag recovery, sitting alongside rather than instead of the sleep and circadian compounds, addressing a different layer of the same problem.

6. MOTS-c: For Metabolic and Mitochondrial Recovery

MOTS-c is a peptide encoded not in nuclear DNA but in the mitochondrial genome, which makes it unusual among the compounds on this list. Mitochondria are the structures inside cells that produce energy, and their function is tied tightly to circadian timing: the body runs its metabolic processes on a schedule, and jet lag throws that schedule into disarray. MOTS-c regulates metabolic homeostasis and supports mitochondrial function, and the reasoning for its inclusion in jet lag protocols follows from that: circadian misalignment disrupts the timing of energy metabolism, mitochondrial efficiency drops alongside sleep quality, and the body's capacity to handle irregular schedules degrades over repeated crossings.

No human trial data has been published for MOTS-c in jet lag as of 2026. Its inclusion in recovery protocols is based on mechanistic reasoning extended from animal and cellular research on its metabolic effects, supported by anecdotal reports from biohackers using it during the adjustment window. Community protocols typically place it on the second day after arrival as part of a broader recovery stack. People who travel on rotating schedules, particularly flight crew with continuous irregular departures, are the community that uses it most, reasoning that mitochondrial support across repeated rotations adds up over time in ways that acute symptom management alone does not address.

MOTS-c is available through research chemical channels and some compounding pharmacies. Given the thin evidence base for this specific application, it is best understood as an emerging option that the performance and biohacking community is actively exploring. That characterization should be kept in mind when weighing it against the better-supported entries earlier in this list.

How These Peptides Compare

Frequently Asked Questions

Are any peptides FDA-approved for jet lag?

No peptide is FDA-approved for jet lag as of 2026, and no drug of any kind currently holds that specific approval either. Tasimelteon, a synthetic melatonin receptor agonist that is not a peptide, has Phase III human trial data for jet lag and has been navigating the FDA approval process, but final approval had not been granted as of mid-2026. The peptides covered here are available as research chemicals or through licensed compounding pharmacies under physician supervision, not as approved therapeutics for this indication.

How do these peptides compare to just taking melatonin?

Melatonin has considerably stronger human clinical evidence for jet lag than any peptide on this list. A randomized study with 474 travelers found roughly a 50 percent average reduction in subjective jet lag, and that evidence profile is well ahead of the community-reported and mechanistic basis for the peptides here. Practitioners who include peptides in their protocols typically frame them as additions to an approach that already includes melatonin and behavioral adjustments, not replacements. The peptides address dimensions melatonin does not target directly, including deep sleep architecture, cognitive recovery, cortisol management, immune vulnerability, and circadian priming over multiple trips.

How long before jet lag peptides show an effect?

This varies by compound and by how many time zones were crossed. Community protocols using DSIP report noticeable improvement in sleep quality on the first or second night at the destination. Epitalon is a longer-game compound used over a series of days before and after travel, with effects described as cumulative rather than immediate. No clinical timeline has been established for any peptide on this list in the context of jet lag, so the honest answer is that the available timelines come from user-reported accounts rather than controlled measurement.

Do pilots and flight crew actually use these compounds?

Peptide use is documented in communities focused on aviation performance and crew recovery, with DSIP, Epitalon, Semax, and Selank all appearing in practitioner-developed protocols for pilots and flight attendants dealing with continuous circadian disruption. That said, Semax and Selank are not approved for flight duty under FAA guidelines, and any compound used by a pilot or crew member in the United States needs to be evaluated against that regulatory framework. The community that uses these compounds tends to focus on off-duty recovery rather than on-duty performance for that reason.

Is it safe to combine several of these peptides?

No peptide combination for jet lag has been evaluated for safety in a controlled human study, so any multi-compound stack is used outside the bounds of published safety evidence. The individual safety profiles, where any published data exists, generally report mild and transient effects such as injection site reactions, headache, and occasional fatigue, though severe reactions including allergic responses have been reported with peptides generally. Physician oversight is the relevant safeguard, and sourcing from regulated compounding pharmacies rather than unverified online suppliers matters meaningfully for product quality and safety.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of peptides for jet lag in one place.